U.S. Physical Therapy (NYSE:USPH) Given Outperform Rating at Barrington Research

Barrington Research reaffirmed their outperform rating on shares of U.S. Physical Therapy (NYSE:USPH) in a research note published on Thursday,Benzinga reports. The firm currently has a $108.00 price target on the stock.

Several other research firms have also commented on USPH. Bank of America restated a “neutral” rating and set a $90.00 price target (down from $114.00) on shares of U.S. Physical Therapy in a research report on Monday, October 7th. StockNews.com upgraded U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st.

U.S. Physical Therapy Trading Down 0.2 %

USPH opened at $95.08 on Thursday. U.S. Physical Therapy has a 52 week low of $76.18 and a 52 week high of $113.63. The business has a fifty day simple moving average of $83.62 and a 200-day simple moving average of $91.44. The firm has a market cap of $1.43 billion, a P/E ratio of 101.15, a P/E/G ratio of 4.40 and a beta of 1.38. The company has a quick ratio of 1.88, a current ratio of 1.78 and a debt-to-equity ratio of 0.27.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Tuesday, August 13th. The company reported $0.73 EPS for the quarter, missing the consensus estimate of $0.82 by ($0.09). U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The firm had revenue of $167.19 million for the quarter, compared to analysts’ expectations of $163.34 million. During the same quarter in the prior year, the business earned $0.76 earnings per share. The company’s quarterly revenue was up 10.4% on a year-over-year basis. On average, equities analysts expect that U.S. Physical Therapy will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Friday, November 15th will be paid a $0.44 dividend. This represents a $1.76 annualized dividend and a dividend yield of 1.85%. The ex-dividend date of this dividend is Friday, November 15th. U.S. Physical Therapy’s payout ratio is currently 187.23%.

Insider Activity

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,724 shares of the firm’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total value of $142,230.00. Following the sale, the chief operating officer now directly owns 7,038 shares in the company, valued at $580,635. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,724 shares of U.S. Physical Therapy stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total transaction of $142,230.00. Following the completion of the sale, the chief operating officer now directly owns 7,038 shares of the company’s stock, valued at $580,635. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Kathleen A. Gilmartin purchased 2,000 shares of the firm’s stock in a transaction on Tuesday, September 3rd. The shares were acquired at an average cost of $86.09 per share, with a total value of $172,180.00. Following the completion of the acquisition, the director now directly owns 18,904 shares in the company, valued at $1,627,445.36. The trade was a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 1.70% of the company’s stock.

Institutional Trading of U.S. Physical Therapy

A number of institutional investors have recently bought and sold shares of USPH. Vanguard Group Inc. increased its position in U.S. Physical Therapy by 1.0% in the 1st quarter. Vanguard Group Inc. now owns 1,072,602 shares of the company’s stock valued at $121,065,000 after acquiring an additional 10,175 shares during the period. Dimensional Fund Advisors LP increased its position in U.S. Physical Therapy by 2.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 423,846 shares of the company’s stock valued at $39,173,000 after acquiring an additional 10,462 shares during the period. Envestnet Asset Management Inc. increased its position in U.S. Physical Therapy by 4.1% in the 2nd quarter. Envestnet Asset Management Inc. now owns 239,982 shares of the company’s stock valued at $22,179,000 after acquiring an additional 9,434 shares during the period. Bank of New York Mellon Corp increased its position in U.S. Physical Therapy by 3.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 157,052 shares of the company’s stock valued at $14,515,000 after acquiring an additional 5,111 shares during the period. Finally, Bahl & Gaynor Inc. increased its position in U.S. Physical Therapy by 1.5% in the 2nd quarter. Bahl & Gaynor Inc. now owns 106,476 shares of the company’s stock valued at $9,841,000 after acquiring an additional 1,623 shares during the period.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.